Predicting drug metabolism -: An evaluation of the expert system METEOR

被引:51
作者
Testa, B [1 ]
Balmat, AL
Long, A
Judson, P
机构
[1] Univ Lausanne, Inst Med Chem, CH-1015 Lausanne, Switzerland
[2] Univ Leeds, Dept Chem, Lhasa Ltd, Leeds LS2 9HD, W Yorkshire, England
关键词
D O I
10.1002/cbdv.200590064
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The paper begins with a discussion of the goals of metabolic predictions in early drug research, and some difficulties toward this objective, mainly the various substrate and product selectivities characteristic of drug metabolism. The major in silico approaches to predict drug metabolism are then classified and summarized. A discrimination is, thus, made between 'local' and 'global' systems. In its second part, an evaluation of METEOR, a rule-based expert system used to predict the metabolism of drugs and other xenobiotics, is reported. The published metabolic data of ten substrates were used in this evaluation, the overall results being discussed in terms of correct vs. disputable (i.e., false-positive and false-negative) predictions. The predictions for four representative substrates are presented in detail (Figs. 1-4), illustrating the interest of such an evaluation in identifying where and how predictive rules can be improved.
引用
收藏
页码:872 / 885
页数:14
相关论文
共 60 条
[1]   Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors [J].
Afzelius, L ;
Zamora, I ;
Masimirembwa, CM ;
Karlén, A ;
Andersson, TB ;
Mecucci, S ;
Baroni, M ;
Cruciani, G .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (04) :907-914
[2]  
[Anonymous], 2003, HYDROLYSIS DRUG PROD
[3]  
BALANI SK, 1995, DRUG METAB DISPOS, V23, P266
[4]   Using absolute and relative reasoning in the prediction of the potential metabolism of xenobiotics [J].
Button, WG ;
Judson, PN ;
Long, A ;
Vessey, JD .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2003, 43 (05) :1371-1377
[5]   Molecular characterization of binding of substrates and inhibitors to DT-diaphorase: Combined approach involving site-directed mutagenesis, inhibitor-binding analysis, and computer modeling [J].
Chen, SA ;
Wu, KB ;
Zhang, D ;
Sherman, M ;
Knox, R ;
Yang, CS .
MOLECULAR PHARMACOLOGY, 1999, 56 (02) :272-278
[6]  
CRUCIANI G, 2005, IN PRESS PHARMACOKIN
[7]   A novel approach to predicting P450 mediated drug metabolism. CYP2D6 catalyzed N-dealkylation reactions and qualitative metabolite predictions using a combined protein and pharmacophore model for CYP2D6 [J].
de Groot, MJ ;
Ackland, MJ ;
Horne, VA ;
Alex, AA ;
Jones, BC .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (20) :4062-4070
[8]   Novel approach to predicting P450-mediated drug metabolism: Development of a combined protein and pharmacophore model for CYP2D6 [J].
de Groot, MJ ;
Ackland, MJ ;
Horne, VA ;
Alex, AA ;
Jones, BC .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (09) :1515-1524
[9]   Development of a combined protein and pharmacophore model for cytochrome P4502C9 [J].
de Groot, MJ ;
Alex, AA ;
Jones, BC .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (10) :1983-1993
[10]   Modeling the active sites of cytochrome P450s and glutathione S-transferases, two of the most important biotransformation enzymes [J].
DeGroot, MJ ;
Vermeulen, NPE .
DRUG METABOLISM REVIEWS, 1997, 29 (03) :747-799